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Abstract 
During the last decade, there has been a rapidly increased appreciation of the role of 
translation as a key regulatory node in gene expression. Thereby, the development of 
methods to infer the translatome, which refers to the entirety of mRNAs associated with 
ribosomes for protein synthesis, has facilitated the discovery of new principles and 
mechanisms of translation and expanded our view of the underlying logic of protein 
synthesis. Here, we review the three main methodologies for translatome analysis, and we 
highlight some of the recent discoveries made using each technique. We first discuss 
polysomal profiling, a classical technique that involves the separation of mRNAs depending 
on the number of bound ribosomes using a sucrose gradient; and which has been 
combined with global analysis tools such as DNA microarrays or high-throughput RNA 
sequencing to identify the RNAs in polysomal fractions. We then introduce ribosomal 
profiling, a recently established technique that enables the mapping of ribosomes along 
mRNAs at near nucleotide resolution on a global-scale. We finally refer to ribosome affinity 
purification techniques that are based on the cell-type specific expression of tagged 
ribosomal proteins, allowing the capture of translatomes from specialised cells in 
organisms. We discuss the advantages and disadvantages of these three main techniques 
in the pursuit of defining the translatome, and we speculate about future developments. 
 
 
  
4 
 
Introduction 
The development of sophisticated ’omics’ technologies paved the way for a systems-level 
understanding of gene expression. Among the modern ‘omics’ approaches, the 
measurement of the level of the entire set of RNAs (the transcriptome) became very 
popular because simple and reliable tools are available for RNA extraction and global 
quantification with DNA microarrays or high-throughput RNA sequencing (RNA-seq). 
Although transcriptome analysis gives a good indication about changes in gene expression 
instigated by drugs, hormones or in disease, the significance is limited by the fact that 
mRNA levels do not necessarily correlate with the levels of proteins they encode [1-3]. 
Besides protein degradation, the observed variability is likely attributed to the control of 
protein synthesis. Thus, the analysis of the translatome, which refers to all mRNAs 
recruited to ribosomes for protein synthesis [4], can reveal important regulatory cues and 
discover relevant pathways linked to disease [5-7].  
Protein synthesis is mediated by the ribosome, which is a large ribonucleoprotein complex. 
The eukaryotic ribosome is comprised of four ribosomal RNAs (rRNAs) and 79 ribosomal 
proteins (RPs), which are shared by two subunits referred to as the large (60S) and small 
(40S) ribosomal subunit [8, 9]. The process of translation can be divided into three steps: 
initiation, elongation and termination [10]. During initiation, which is thought to be the 
primary target for translational control, translation initiation factors (eIFs) recruit the mRNA 
to the small ribosomal subunit (40S subunit). The so-formed initiation complex then scans 
the mRNA from 5’ to 3’ until the initiation codon is reached. At this point, the 60S subunit 
joins the complex leading to the formation of a fully assembled 80S ribosome. Of note, 
ribosomes can also be recruited cap-independently to some viral and cellular mRNAs by 
direct binding of the small ribosomal subunit to internal RNA structures, termed IRES [11]. 
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During the elongation phase, the ribosome and another set of accessory proteins termed 
elongation factors (eEFs), move along the coding region of the mRNA and synthesise the 
encoded polypeptide, with multiple ribosomes covering the mRNA to form polysomes. 
Finally, at the termination codon, peptide chain-release factors (eRFs) assist the release of 
the nascent polypeptide and dissociate ribosomes from the mRNA [10].  
Translation can be controlled on a global level or on specific mRNAs (reviewed in [10, 12]). 
Global control can be achieved by phosphorylation of eIFs, such as of eIF2that reduces 
the amount of active initiation complexes and leads to a rapid reduction of the translation of 
most mRNAs. Global control is also achieved by controlling the bioavailability of eIFs 
through interacting proteins, for example eIF4E is controlled by 4E-binding proteins (4E-
BPs) that compete for binding of eIF4E with eIF4G, and thus inhibit association of the small 
ribosomal subunit with the mRNA [12]. Conversely, the translation of specific mRNAs can 
be regulated by trans-acting RNA-binding proteins (RBPs), which often bind to sequence or 
structural elements in untranslated regions (UTRs) of the mRNA and, for instance, repress 
or activate translation via interactions with eIFs [13]. Likewise, certain classes of non-coding 
RNAs (ncRNAs), such as microRNAs (miRNAs; small RNAs of 22 nucleotides in length) 
can repress translation via base pairing to sequences located in 3’-UTR of target mRNAs 
[14]. Finally, translation is also controlled by other types of cis-acting elements residing in 
the mRNA that more directly interact with ribosomes such as IRESs (see above [11]), 
upstream ORFs (uORFs) [15] or sites of programmed frame-shifting within coding 
sequences [16].  
The increased recognition of the richness and impact of translation regulation for cell 
function and disease has come along with the development of sophisticated tools that allow 
the investigation of translation and the underlying regulatory events on a global-scale. 
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Herein, we provide a brief overview of the main methodologies currently used to profile the 
translatome; starting with polysomal profiling developed in the 1960s and proceeding to the 
more recently evolved ribosomal profiling and affinity-capture techniques.  
Polysomal profiling – the traditional “gold standard” 
A reliable measure for translation of a cellular mRNA is the degree of its association with 
ribosomes. Since the rate of initiation usually limits translation, most translational responses 
will alter the ribosome density on a given mRNA. During polysomal profiling, actively 
translated mRNAs bound by several ribosomes (polysomes) are separated from the “free” 
RNA, the small (40S) and the large (60S) ribosomal subunits and the 80S monosomes by 
sucrose gradient centrifugation (Figure 1; for a recent polysomal profiling protocol see [17]). 
After isolation of RNA from fractions of the gradient, the distribution of specific mRNAs in 
the gradient can be monitored by Northern blot or reverse-transcription quantitative PCR 
(RT-qPCR), or on a global level using cDNA microarrays, or more recently with RNA-seq 
(for RNA-seq examples see [18, 19]). Of note, polysomal profiling likewise enables 
monitoring of proteins associated with initiation complexes and/or ribosomes by 
immunoblot-blot analysis and/or proteomics [20]. 
The global profiling of mRNAs in each fraction of the polysomal gradient allowed the 
drafting of the first high-resolution maps of ribosome occupancy and densities on all 
individual mRNAs expressed in healthy “normal” cells [21-23]. Nevertheless, most genome-
wide studies to date have used polysomal profiling to compare the translational status of 
mRNAs in different cell-types (e.g. healthy vs. cancer cells) or of cells subjected to 
intrinsically or extrinsically induced conditions in order to reveal translationally regulated 
messages. The analysis is thereby based on the well-established assumption that a shift of 
a mRNA in the polysomal gradient is indicative of an altered translational status of the 
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respective mRNA. To simplify the analysis, mostly “low-resolution profile” analysis has been 
performed, such that mRNA contents of high sucrose gradient fractions (polysomes) were 
compared with fractions from low sucrose gradient fractions (the pool of non-translated 
mRNAs) (Fig. 1, left). In parallel, changes in the levels of total RNA are often measured to 
study the relationship between transcription/decay and translation under different 
conditions. Early examples refer to investigations of global changes of translatome under 
different physiological conditions in yeast [24], and the approach was also adapted to 
mammalian cells to investigate, for instance, the response to diverse stressors/stress-
situations such as apoptosis [25], endoplasmic reticulum (ER)-stress [26], hypoxia [27], and 
viral infection [28]. More recent examples refer to the translational response of cells 
exposed to ultra-violet (UV) irradiation which induces the DNA-damage response, and cells 
appear to cope by the selective recruitment of mRNA encoding for DNA-repair enzymes to 
the polysomal fractions [29, 30]. Translationally deregulated mRNAs were also identified 
during the inflammatory response in several studies [29, 31]: this includes the contribution 
of translational regulation to the early phase of the macrophage response from mouse 
macrophages stimulated with lipopolysaccharide [29]; or the co-culturing of breast tumour 
cells with conditioned medium of activated monocyte-derived macrophages which revealed 
novel cellular functional IRES located in the 5’UTR of mRNAs [31].  
Besides the application of diverse stress conditions, likewise analysis has been carried out 
to study drug action: for example, a recent global study on the translational targets of 
canonical mTOR inhibitors (mTOR is major pathway controlling signals of nutrient 
availability) revealed that the antidiabetic drug metformin preferentially controls selective 
translational suppression of mRNAs coding for cell-cycle regulators and thus, could 
possibly inhibit mRNAs coding for proteins that promote neoplastic transformation [32]. As 
such, the study could facilitate investigation for the use of this drug in cancer prevention 
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and treatment, and highlights the advantages of translational profiling for studies on drug 
action [32]. Numerous studies have further applied polysomal profiling to test the effect of 
mutants or overexpression of global or specific translational regulators in yeast [33], 
mammalian cells [34]; or to investigate the impact of ncRNAs, such as miRNAs in 
translation [35, 36]. Finally, the comparative analysis of cell lines such as cancer cells (e.g. 
leukaemia [37]); or translational reprogramming during cell-differentiation, as for instance 
during adipogenic differentiation [18]; suggested new potential targets that could open the 
door for future drug development and medical intervention. Noteworthy, although most 
studies were conducted in yeast and mammalian cells, global polysomal profiling has also 
been amended to other cells or organisms, such as the study of translational regulation 
events upon stress in bacteria [38] and plants [39], or of developmental programs in the 
fruitfly Drosophila melanogaster [40]. 
Although sucrose density fractionation has for a long time been recognised as the ‘‘gold 
standard” to monitor active translation, there are some drawbacks that may have hindered 
its integration by the wider research community (Table 1). It requires specialised and 
expensive equipment (e.g. ultracentrifuge, gradient fractionation system) that may not be 
available in every laboratory and the procedure is labour intensive and does not allow 
handling of many samples in parallel. Furthermore, the samples are usually diluted in 
sucrose solution containing heparin (a potent RNase inhibitor) making more elaborate 
precipitation steps necessary to isolate RNA of sufficient quality for microarray/ RNA-seq 
analysis. Additionally, polysomal fractions may be contaminated with other high molecular 
weight complexes that are not an integral part of ribosomes, such as lipid rafts, processing 
body components or pseudo-polysomes [41]. Finally, we wish to note that polysomal as 
well as ribosome profiling (see below) requires a relatively large sample size, in the range 
of ten million cells, to obtain sufficient RNA for microarray/ RNA-seq analysis. Thus, the 
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methods are less amenable to samples or tissues of low abundance, such as cancer 
patient tissue biopsies.  
Ribosomal profiling – determining the position of ribosomes at codon resolution 
The advances in sequencing technology inspired the development of the ribosomal profiling 
technique, which provides a global measure of translation at near nucleotide resolution [42]. 
The technique is based on deep sequencing of ribosome protected RNA fragments (RPFs) 
that persist after treatment of a cell lysate with RNaseI, and thus enables the exact 
measurement of ribosome positions and densities along all RNA molecules present in a cell 
(Figure 1; for a detailed protocol [43]). In analogy to polysomal profiling, the analysis is 
based on the approximation that reading of the average ribosome density per mRNA 
correlates to the synthesis level of the corresponding protein, assuming that elongation 
rates are constant. In addition, a triplet periodicity should be seen in the sequencing data 
with peaks at the first nucleotide position, as the ribosome moves along the mRNA in a 
step-wise fashion one codon at a time beginning at the start codon [43-45]. In order to 
define the translatome, total mRNA extraction and sequencing is performed in parallel, to 
normalise RPFs to mRNA abundance.  
The ribosomal profiling technique was originally developed in the Weissman lab in the yeast 
Saccharomyces cerevisiae, where ribosomal profiles of cells grown under rich and amino-
acid starvation conditions were compared [42]. It was found that one third of genes 
underwent a change in translational efficiency between the two conditions; thereby mRNA 
encoding proteins involved in ribosome biogenesis were prevalent in the translationally 
repressed fraction during starvation conditions [42]. Besides the systematic identification of 
translationally regulated messages - which has been previously achieved with “traditional” 
polysomal profiling (see above) - the true strength of the technique is the global acquisition 
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of positional information in regard to the location of where the ribosomes are positioned 
along the mRNA. In this respect, the study by Ingolia et al. disclosed previously 
undiscovered uORFs engaged with ribosomes, and numerous potentially novel non-AUG 
start codons [42].  
Since then, the technique became very rapidly adapted to different cellular systems and 
organisms to investigate translational control during diverse stress conditions, drug action 
or fundamental cellular processes (for a detailed review [44, 45]). Examples include the 
translational response of yeast to oxidative stress [46]; the response of mammalian cells to 
heat shock [47] and proteotoxic stress [48]; the (re-)investigation of drug action, namely 
inhibitors of the mTOR pathway in mouse embryonic fibroblasts or prostate cancer cells 
[49, 50]; and deciphering translational control during yeast meiosis [51] or cell-cycle 
progression in human cultured cells [52]. Ribosomal profiling has also been adapted to 
study the impact of specific trans-acting factors on translation such as miRNAs and RBPs 
[53-55]. Besides further modification of the biochemical procedure, the establishment of 
rigorous bioinformatic analysis of the ribosome footprint sequencing data was key to 
deciphering novel and surprising insights into translational control. This includes the 
discovery of features related to translation initiation such as uORFs [42, 56], non-AUG 
initiation codons [56, 57], novel coding transcripts [51], or novel protein isoforms arising 
from N-terminal extensions/truncations [57, 58]. It also enabled the accurate measurements 
of elongation rates or decoding speeds of individual codons [59, 60], mapping of 
translational pause sites [61], and the study of co-translational folding [62].  
To date, two major variants of the technique can be distinguished which relate to the 
preferred mapping of either elongating and/or initiating ribosomes. To map the position of 
all ribosomes on mRNAs, cells are commonly treated with cycloheximide (CHX), which is 
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an antibiotic that rapidly diffuses in to cells and stalls both initiating and elongating 
ribosomes. However, recently it was claimed that treatment of cells with CHX can introduce 
prominent artefacts in ribosome profiling data [63]. In particular, there is evidence that 
treatment of stressed cells with the most commonly used concentration of CHX (100 µg/ml) 
can cause the accumulation of RPFs shortly downstream of the start codon, an effect not 
seen using either no CHX or high concentrations [63]. This finding challenges conclusions 
drawn from ribosomal profiling studies applying CHX which suggest that accumulation of 
ribosomes around the start site of coding sequences (the so-called ribosome “ramp”) is due 
to either slow elongation [64] or to the change in recruitment of ribosome-associated 
chaperones [48].  
To accurately map initiating ribosomes, antibiotics other than CHX are preferentially used 
that specifically stall ribosomes at translation initiation sites (TIS) [65]. In a first application, 
mouse embryonic stem cells were treated with harringtonine, a compound that binds to free 
60S subunits and is thought to effectively inhibit translation initiation [61]. Indeed, 
harringtonine caused a profound accumulation of RPFs at the beginning of CDS, and its 
application uncovered an unexpected number of alternative translational initiation codons 
and uORFs with regulatory potential, whose ribosome coverage and translation changed 
after differentiation [61]. Because the full extent to which harringtonine blocks translation 
initiation is not well resolved, Lee and colleagues used a combination of CHX and 
lactimidomycin (LTM) to differentiate between elongating ribosomes and initiating 
ribosomes, respectively [56] . Like CHX, LTM binds in the E-site of the ribosome, but due to 
its size, LTM is only recruited to ribosomes lacking tRNA thereby specifically inhibiting 
translation initiation. As with the previous study, they also identified an unexpectedly high 
number of novel initiation sites and uORFs in HEK293 and a mouse embryonic fibroblast 
cell line. In fact, only 51% of initiation events occurred at AUG codons in HEK293 cells, with 
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the remainder occurring at other triplets including CUG [56]. Fritsch and colleagues 
performed likewise analysis to obtain a transcriptome-wide map of TISs in a human 
monocytic cell line. Thereby, cells were initially treated with the drug puromycin, which 
releases elongating ribosomes from the mRNA, and then with CHX to stall the remaining 
initiating ribosomes [57]. Once more, it was found that only 47% of initiation events 
occurred at annotated AUG codons in ORFs, and suggested the existence of numerous 
novel uORFs and alternative TISs leading to potential N-terminally extended proteins. 
Importantly, a consequence of alternative TIS within a mRNA has recently been revealed 
for a protein involved in interferon signalling, MAVS, leading to the production of either a full 
length or a shorter isoform [58]. Thus, the short isoform of the protein interferes with 
interferon production induced by full-length MAVS, whereas both proteins positively 
regulate cell death [58]. Overall, these studies are intriguing as they suggest that translation 
start sites are much less-well defined than previously anticipated, generally strengthening 
the theory of the importance  of translational control at initiation for cellular physiology. 
Whilst many ribosomal profiling studies were conducted in yeast or cultured mammalian 
cells, the technique also became adapted to other species including viruses [66, 67], 
bacteria [68], worms [69], and zebrafish [70]. For instance, in a recent study, ribosomal 
profiling was carried out to accurately quantify absolute protein synthesis rates in the 
bacteria Escherichia coli, owing to the fact that the average half-life of a protein in E. coli is 
longer than the doubling time [68]. Ribosomal profiling allowed the discovery of key 
principles for protein synthesis in bacteria, such as proportional synthesis, whereby 
translation of proteins in a multi-protein complex encoded on the same polycistronic mRNA 
are precisely controlled at the level of translation to reflect the stoichiometry of the complex 
[68].  
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Although ribosome profiling has proven to be powerful in defining ribosome positions on the 
entire transcriptome, nevertheless the technique also has some challenges: one major 
issue is that ribosomal profiling, like polysomal profiling, relies on fractionation of cell 
extracts through a sucrose gradient/ cushion; and it requires a large amount of starting 
material (10 million cells) to get a reasonable amount of RNA for downstream analysis. 
Moreover, the method is labour intensive (~7 days) and thus not suitable for high-
throughput applications. There are also issues that could lead to artefacts and 
misinterpretation of data. For example, pseudoRPFs could arise from structured double 
stranded regions of RNA, as RNaseI only degrades single stranded RNA, thus double 
stranded RNA is artificially protected as an RPF. The shortness of RPF sequences also 
obscures the analysis of distinct mRNAs subpopulations (e.g. splice forms, alternate 5’ and 
3’ UTRs) that may be translated at different levels and could be occupied by different 
numbers of ribosomes (e.g. splice isoforms, alternate 5’ and 3’ UTRs). 
Ribosome affinity purification – capturing the translatome of specialised cells 
Gene expression studies from particular cells types are limited by difficulties of isolation 
without substantial contamination from other surrounding cells or tissues. Ribosome affinity 
purification (RAP) or translating RAP (TRAP) has thus become increasingly popular as a 
new tool to monitor gene expression in specific cell-types such as neurons and stem cells 
[71]. Therefore, genetically modified cells/organisms are constructed which express an 
affinity-tagged ribosomal protein of the large (60S) ribosomal subunit in vivo. Importantly, 
the expression of the tagged RPs can be controlled by a tissue-specific promotor, such as 
the Gal4-UAS system in D. melanogaster or the Cre-lox system in mice. The tissue is then 
collected and tagged ribosomes are recovered by affinity selection, capturing only those 
ribosomes that are expressed in the cells of interest (Figure 1). Finally, the RNA is isolated 
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from the captured ribosomes and quantitatively measured with microarrays/ RNA-seq. Of 
note, since entire ribosomes are captured, which includes monosomes and polysomes, 
RAP/TRAP does not provide a high-resolution map of the translational status of a mRNA as 
polysomal profiling does. Nevertheless, because translation is primarily regulated at the 
initiation step, before the 80S ribosomes are formed on the mRNA, RAP and translatome 
analysis gives a very good approximation of the translation status of mRNAs; and if 
combined with transcriptome analysis, it can unravel translational regulation [4, 72]. 
In a first application, Inada and colleagues used FLAG-(His)6-tagged ribosomal protein L25 
(Rpl25p) to capture monosomes and polyribosomes (polysomes) from yeast 
Saccharomyces cerevisiae extracts with an anti-FLAG agarose affinity resin [73]. Although 
ribosomal proteins, ribosomal RNAs (rRNAs) and mRNAs were successfully co-purified 
with the Rpl25p bait, large polysomes (> 5 ribosomes) were underrepresented and hence, it 
was concluded that the strategy may not adequately reflect the translational status of 
mRNAs. However, a selection screen for tagged RPs that fully integrate into translating 
polysomes, as well as biochemical improvements (use of microbeads instead of 
agarose/sepharose for affinity isolation), enabled the efficient capture of ribosome 
associated RNA for translatome analysis in yeast [74]. Thereby, affinity-tagged Rpl16a was 
used to profile alterations of the translatome upon different stress conditions, and 
comparison of translatome changes with that of the transcriptome revealed that RAP is 
suitable to detect translational regulation events with high sensitivity [4]. In particular, it was 
found that severe stress to cells imposed highly co-ordinate programs between the 
transcriptome and the translatome, whereas mild stress lead to a non-correlated response 
preferentially changing the translatome, providing further evidence that translational 
regulation events are key for rapid adaptation to changing environmental conditions [74]. 
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Whereas the study of the translatome in unicellular organisms like yeast provides a 
valuable alternative to classical polysomal profiling with diverse applications, e.g. [75], RAP 
has now become of great interest to profile gene expression of specific cell-types in both 
plants and animals. In plants, RAP was initially established in Arabidopsis thaliana by the 
Bailey-Serres laboratory [76]. They engineered plants that allowed for cell-specific 
expression of FLAG-tagged-Rpl18 via developmentally regulated promotors, and quantified 
differentially expressed mRNAs of 21 different cell-types under normal and hypoxic 
conditions with DNA microarrays [77]. The study provided a first atlas of translated mRNAs 
within a cell population of seedlings and explored cell-specific adjustments in response to 
hypoxia. RAP was also implemented to profile gene expression in multiple zones of the 
Arabidopsis floral meristem and developing flowers [72]. The latter study also compared the 
translatome with the transcriptome using a deep sequencing approach, which revealed 
widespread post-transcriptional regulation at both the intron-splicing and translational 
stages; and they identified a new class of non-coding RNAs associated with polysomes 
[72].  
In animals, RAP was first established in mice [78, 79]. The Heintz lab used bacTRAP 
transgenic mice to drive expression of enhanced green fluorescent protein (eGFP)–tagged-
Rpl10a in different neuronal cell types, followed by the affinity purification of eGFP-labelled 
ribosomes with anti-GFP antibodies and subsequent microarray analysis of associated 
mRNAs [78]. To further validate their approach, which they referred to as TRAP, they 
profiled the translatomes of twenty-four CNS cell populations, identifying thousands of cell-
specific mRNAs that could not be detected in whole-tissue microarray studies, and which 
demonstrated the benefits of TRAP for comparative analysis of gene expression across 
different cell-types [80]. While these initial studies were based on the tissue specific 
expression of GFP-L10a using BAC transgenes such that each lineage of interest required 
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construction of a new transgenic mouse line, several TRAP mouse lines have now been 
constructed in which lineage-selective Cre activates expression of tagged Rpl10a. Given 
the large number of available Cre driver lines, such conditional TRAP mouse models now 
greatly broadens the applicability of the technology; for instance to profile for markers and 
pathways in mouse disease models [81-83]. For example, EGFP-L10a was targeted into 
the ubiquitously expressed Rosa26 locus in murine embryonic stem cells (ES) and TRAP 
was conducted to identify genes that are differentially expressed in a cardiomyocyte 
disease model [81]. Likewise, the distinct cellular responses in an ischemia reperfusion 
injury mouse model of acute kidney injury (AKI) were investigated [82]; and translatome 
profiling in myofibroblasts during kidney fibrosis revealed new potential biomarkers [84]. In 
order to define changes in the translatome versus changes in the transcriptome, a 
commonly used method is to compare the translatome from the tagged-ribosome cell 
population, with total RNA isolated from the entire tissue [78, 80, 83]. An alternative 
approach, explored by Hupe and colleagues, involved comparing TRAP-mRNAs from the 
tagged cell of interest with TRAP-mRNAs from the whole tissue containing the tagged cell 
of interest, but this requires the generation of two different Cre driver lines, and was found 
to be important only when studying abundant cell populations [83].  
Recently, TRAP has also been implemented for cancer studies, in particular to study the 
radiation response of glioma cells in a mouse model of proneuronal glioblastoma [85]. A 
recent innovative study modified TRAP by tagging Rpl10a with a camelid nanobody raised 
against GFP [86]. The nanobody fused to ribosomes stably binds to intracellular GFP, 
which then allows for ribosome capture from cell-lysates with anti-GFP antibodies that 
recognise a different epitope than the nanobody. The approach was used to capture 
translating mRNAs from neurons injected with a retrogradely transported tracing GFP-
tagged virus (canine adenovirus type 2), allowing the identification of markers which 
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delineate between cell-types projecting into the nucleus accumbens [86]. Finally, TRAP in 
non-transgenic animal has recently been demonstrated through viral infection of Purkinje 
cells in mice [87]. Combining micro-dissection with TRAP on cytoplasmic and rough 
endoplasmic reticulum (ER) provided an advanced map of the expression landscape of 
Purkinje cells and its dendrites [87].  
Besides yeast, plants and mice, RAP/TRAP became has also been adapted to other model 
organisms: in the fruitfly D. melanogaster, the use of the GAL4/UAS system allows for 
profiling of almost any tissue/cell-type. For example, TRAP was employed to quantify 
neuronal expression in heads and to capture the translated RNAs from small populations of 
neuro-secretory cells in adult brains [88]. In zebrafish (Danio rerio), TRAP was applied to 
profile translating RNAs in cardiomyocytes during heart regeneration [89], and to measure 
the impact of a short heat-shock on the expression of selected mRNAs in neutrophils, 
macrophages, and epithelial cells [90]. Finally, TRAP was used in frogs (Xenopus laevis) 
[91] to isolate mRNAs from retinal ganglion cell axons and rod photoreceptors [92].  
Conclusions and perspectives 
Polysomal profiling was the first method which hinted at the scope of translational control; it 
allowed us to recognise for the first time that just because a mRNA is transcribed, it doesn’t 
mean that it is “automatically” translated, and that a mRNA may be translated under one 
particular condition only. However, it wasn’t until the advent of ribosomal profiling that the 
understanding of the complexity of translational control really began to gather pace. The 
power of the positional information conferred by ribosomal profiling is revealing not only 
dynamic changes to the translatome during different conditions, but also the cis- and trans-
acting control mechanisms by which these changes can be conferred. Furthermore, parallel 
development of affinity-tagged approaches allowed for cell/tissue-type specific profiling of 
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ribosomes from complex heterogeneous samples. This category of translatome analysis 
method also tends to be reliable, quick and efficient, as it relies on a robust 
immunoprecipitation against a well-defined tag.  
Nonetheless, refinement and further development of the current methods for translational 
profiling are in need as all three methods are not without fault (Table 1). Whereas 
polysomal and ribosomal profiling require relatively large sample size, and involve laborious 
biochemical purification on a sucrose density gradient prone to contamination; the affinity-
purification techniques often require the expression of exogenously tagged RPs and thus, 
capture only a fraction of all ribosomes in cells. The combination and further iteration of the 
three main methodological-themes bears the potential to cope with the issues related to 
each individual approach. Indeed, two recent papers reported the combination of either 
affinity purification or polysomal fractionation, with ribosomal profiling: Juntawong and 
colleagues combined ribosome affinity purification and ribosomal profiling to map the 
translatome of Arabidopsis during normoxic and hypoxic conditions [93]; and Aspden and 
colleagues profiled translation in Drosophila S2 cells using “poly-ribo-seq”, whereby 
polysomal fractions obtained from sucrose density gradients are used for subsequent 
ribosomal profiling [94].  
An additional consideration when measuring the translatome to infer the proteome, is the 
post-translational regulation of produced proteins; if a protein is produced then rapidly 
degraded, the translational status of that protein may not correlate with the protein level. 
For example, the hypoxia inducible factor 1 alpha (HIF1α) is translated and rapidly 
degraded during normoxic conditions [95]. In such instances, it may be useful to measure 
the proteome in parallel with the translatome, and indeed, recent work using a combination 
of LC-MS/MS and ribosomal profiling was able to demonstrate the presence of several N-
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terminally extended proteins that either method alone was not able to reliably identify [96, 
97]. 
Looking forward, further advancement of translatome analysis is likely to require the 
development of entirely new biochemical methods that enable easy, rapid, and reliable 
isolation of ribosomes from small numbers of cells or even a single cell. Likewise, improved 
and simplified bioinformatics will be key for streamlined analysis of the fast data generated 
from RNA-seq and to generate models (e.g. [98]). If this could be accomplished, 
translatomics may become as widely used as transcriptomics and become applicable for 
integration in high-throughput functional genomics screens.  
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Key Points 
 Translational control is known to play a pivotal role in the gene expression 
programme, and as such, analysis of the translatome (the set of mRNA undergoing 
translation) is critical for the understanding of gene expression. 
 Three main approaches for translatome analysis are currently used; polysome 
profiling, ribosome profiling and ribosome-affinity techniques.  
 Polysome profiling separates mRNA based on the number of associated ribosomes 
on a sucrose gradient, but suffers from the need for specialised equipment, large 
sample size requirements and has potential for contamination with other 
macromolecular complexes.  
 Ribosomal profiling involves the sequencing of ribosome-protected mRNA fragments 
(RPFs) and generates highly informative ribosome-positional information, but 
requires a large sample size and has potential for pseudo-RPF contamination. 
 Ribosome affinity purification involves the isolation of affinity-tagged ribosomes and 
allows for cell-type specific translatome analysis, but suffers from the requirement for 
genetic manipulation. 
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Figure legend 
Figure 1: Experimental approaches to study the translatome 
Cell-extracts are usually prepared in the presence of cycloheximide (CHX), which is a 
potent inhibitor of translational elongation. (Left) Polysomal profiling; extracts are separated 
by ultracentrifugation through a linear 10–50% sucrose density gradient. The gradient is 
then fractionated while continuously monitoring the absorbance at 254 nm (A254) allowing 
the separation of ‘‘free” RNA, the small (40S) and large (60S) ribosomal subunits, 
monosomes (80S), and polysomes. RNA is isolated from individual gradient fractions and 
pooled for subsequent microarray or RNA-seq analysis. The relative position of a message 
in this profile is an indicator of its translational activity. (Middle) Ribosomal profiling; extract 
is treated with RNaseI to digest unprotected and non-ribosome bound regions in the 
mRNAs. The ribosomes are further enriched through a sucrose cushion, and ribosome 
protected fragments (RPFs) of RNA are size-fractionated by gel electrophoresis. RPFs of 
approximately 30 nucleotides are recovered and ligated to sequencing adaptors for reverse 
transcription, amplification and high-throughput RNA-seq. Additionally, cDNAs generated 
from rRNA are usually depleted before amplification. (Right) RAP procedure; affinity-tagged 
(e.g. GFP, protein A) ribosomes are captured from extracts with specific antibodies or 
ligands coupled to a matrix. After several stringent washes, the ribosomes and associated 
RNAs are released from the matrix and captured RNAs are analysed with DNA microarrays 
or by RNA-seq. It is possible to combine either polysomal profiling (left), or affinity 
purification (right), with ribosomal profiling (centre), using either of the aforementioned 
methods as a vehicle for enriching the sample with ribosomes before isolating ribosome 
protected fragments. 
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Table 1 
Method Advantages Disadvantages Optimal applications 
Polysomal 
profiling 
(Figure 1, 
left) 
 Ribosome density 
measurement 
 Fractionation by 
ribosome occupancy 
on mRNA 
 
 Specialised 
equipment 
 Large number of cells 
(~107) 
 Labour intensive 
 Pseudopolysome 
contamination 
 Lack of cell-type 
specificity 
 Cultured cells/ tissues 
 Initial screen for 
translational changes 
 To track the 
translational status of 
a given mRNA / 
particular set of 
mRNAs whose 
identity is known 
Ribosomal 
profiling 
(Figure 1, 
centre) 
 Ribosome density 
measurement 
 Ribosome positional 
information 
 Discovery of; new 
uORFs, alternative 
start codons, 
alternative protein 
isoforms, decoding 
speeds, translational 
pause sites, 
translational 
dynamics 
 Specialised 
equipment 
 Large number of cells 
(~107) 
 Labour intensive 
 PseudoRPF 
contamination 
 Expensive (deeper 
sequencing due to 
fragment size) 
 Extensive 
bioinformatics – 
annotation of small 
sequencing 
fragments 
 Lack of cell-type 
specificity 
 Cultured cells/ tissues 
 Dissection of initiation 
and elongation 
events. 
 Determination of 
molecular 
mechanisms of 
translational control  
Ribosome 
affinity 
purification 
(Figure 1, 
right) 
 Smaller number of 
cells (<106) 
 Cell/tissue-type 
specific 
 Simple, cheap, robust 
 Genetic modification 
e.g. transgenes to 
express tagged RPs 
 Lower resolution 
 
 Samples with 
genetically tagged 
ribosomes 
 
 
 
 
 
 
